Literature DB >> 35035739

Laparoscopic radical resection combined with neoadjuvant chemotherapy in treatment of colorectal cancer: clinical efficacy and postoperative complications.

Shengchao Wei1, Jie Xi1, Shuai Cao1, Tao Li1, Jiacheng Xu1, Wei Li1, Yuhe Bi1.   

Abstract

OBJECTIVE: To explore the clinical efficacy of laparoscopic radical resection combined with neoadjuvant chemotherapy (NACT) in the treatment of colorectal cancer and its influence on postoperative complications.
METHODS: The clinical data of 90 patients with colorectal cancer admitted to our hospital from June 2019 to June 2021 were retrospectively analyzed. According to different treatment methods, patients were divided into a control group (laparoscopic radical resection) and a study group (combined NACT before radical resection), with 45 cases in each group. The efficacy and complications were compared between the two groups after treatment.
RESULTS: Postoperatively, the early oral feeding, anal exhaust time, and hospitalization time of the patients in the study group were significantly shorter than those in the control group (P<0.05). The study group had significantly lower cancer metastasis rate, recurrence rate, infection rate, and smaller tumor diameters than the control group (P<0.05). The levels of tumor markers (CEA, CA242, CA199, and CA724) were reduced significantly in both groups after treatment, with lower results observed in the study group (P<0.05). The average survival time of patients in the study group was significantly longer than that of the control group (16.04±3.64 vs 11.88±2.53 months; t=6.295, P<0.001). The two groups showed no significant differences in the incidence of complications (P>0.05).
CONCLUSION: Laparoscopic radical resection of colorectal cancer combined with NACT is a preferred technique for the treatment of colorectal cancer. It effectively facilitates the postoperative recovery, reduces the levels of tumor markers, boosts the short-term curative effect, and prolongs the average survival time, without obvious complications. AJTR
Copyright © 2021.

Entities:  

Keywords:  Laparoscopy; colorectal cancer; complications; neoadjuvant chemotherapy

Year:  2021        PMID: 35035739      PMCID: PMC8748148     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  25 in total

1.  Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study.

Authors:  Marina Baretti; Lorenza Rimassa; Nicola Personeni; Laura Giordano; Maria Chiara Tronconi; Tiziana Pressiani; Silvia Bozzarelli; Armando Santoro
Journal:  Clin Colorectal Cancer       Date:  2018-03-21       Impact factor: 4.481

2.  High ligation of the inferior mesenteric artery with nerve-sparing in laparoscopic surgery for advanced colorectal cancer.

Authors:  Y Sun; Z C Zhang; Y D Zhou; P Li; Q S Zeng; X P Zhang
Journal:  Tech Coloproctol       Date:  2020-10-07       Impact factor: 3.781

3.  Comparison of Right-side and Left-side Colon Cancers Following Laparoscopic Radical Lymphadenectomy.

Authors:  Han Deok Kwak; Jae Kyun Ju; Soo Young Lee; Chang Hyun Kim; Young Jin Kim; Hyeong Rok Kim
Journal:  J Invest Surg       Date:  2019-05-10       Impact factor: 2.533

4.  Clinical Application of Enhanced Recovery After Surgery in Perioperative Period of Laparoscopic Colorectal Cancer Surgery.

Authors:  Qianju Li; Lei Du; Liesheng Lu; Yifeng Tong; Songbo Wu; Yanfei Yang; Qineng Hu; Yukun Wang
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2019-01-07       Impact factor: 1.878

5.  Is neoadjuvant chemotherapy appropriate for patients with resectable liver metastases from colorectal cancer?

Authors:  Fumitoshi Hirokawa; Mitsuhiro Asakuma; Koji Komeda; Tetsunosuke Shimizu; Yoshihiro Inoue; Syuji Kagota; Atsushi Tomioka; Kazuhisa Uchiyama
Journal:  Surg Today       Date:  2018-09-25       Impact factor: 2.549

6.  Optimal use of antiplatelet agents, especially aspirin, in the perioperative management of colorectal cancer patients undergoing laparoscopic colorectal resection.

Authors:  Yasunori Yoshimoto; Takahisa Fujikawa; Akira Tanaka; Hideto Hayashi; Norihiro Shimoike; Hiroshi Kawamoto; Chiyo Nakasuga; Tsunenori Yamamoto
Journal:  World J Surg Oncol       Date:  2019-06-01       Impact factor: 2.754

7.  Neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: a feasibility and safety study.

Authors:  M Leimkühler; P H J Hemmer; A K L Reyners; D J A de Groot; R J van Ginkel; L B Been; G H de Bock; B L van Leeuwen
Journal:  World J Surg Oncol       Date:  2019-01-11       Impact factor: 2.754

8.  Efficacy of intestinal obstruction stent combined with laparoscopic surgery and neoadjuvant chemotherapy in patients with obstructive colorectal cancer.

Authors:  Leilei Yang; Weiwei Ma; Meizhen Wang; Ruili Zhang; Tienan Bi; Shenkang Zhou
Journal:  Oncol Lett       Date:  2019-06-24       Impact factor: 2.967

9.  Comparison of recovery effect for sufentanil and remifentanil anesthesia with TCI in laparoscopic radical resection during colorectal cancer.

Authors:  Yanyan Qi; Xiangyan Yao; Beibei Zhang; Xianhui DU
Journal:  Oncol Lett       Date:  2016-03-31       Impact factor: 2.967

10.  Serial mutational tracking in surgically resected locally advanced colorectal cancer with neoadjuvant chemotherapy.

Authors:  Keishi Sugimachi; Shotaro Sakimura; Shotaro Kuramitsu; Hidenari Hirata; Atsushi Niida; Tomohiro Iguchi; Hidetoshi Eguchi; Takaaki Masuda; Masaru Morita; Yasushi Toh; Yoshihiko Maehara; Yutaka Suzuki; Koshi Mimori
Journal:  Br J Cancer       Date:  2018-08-03       Impact factor: 7.640

View more
  1 in total

1.  Efficacy of Laparoscopic Radical Resection Combined with Neoadjuvant Chemotherapy and Its Impact on Long-Term Prognosis of Patients with Colorectal Cancer.

Authors:  Liang Huang; Xijuan Xu; Jinfan Shao; Weiwen Hong; Wenfeng Yu
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-09       Impact factor: 2.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.